O董那看到,WHO的新公約要在瘟疫流行時取得最多20%的參與國相關資源。 “According to the Agreement, pharmaceutical manufacturers participating in the PABS system will play a key role in equitable and timely access to pandemic-related health products by making available to WHO “rapid access targeting 20% of their real time production of safe, quality and effective vaccines, therapeutics, ...”